Abstract: Volatile contaminants in drinking, ground and waste waters are an ongoing environmental concern throughout the world. Testing for these contaminants is generally done using a Gas Chromatograph (GC) coupled to a Mass Spectrometer. However, sampling for these compounds is dependent on the environmental regulations of the country in which you are testing. The USEPA methods for extracting VOCs from environmental samples require purge and trap sampling. On the other hand, in Europe and Canada, it is common to use static headspace sampling for the measurement of VOCs. Summary: Static headspace sampling has always been a viable option for the detection of Volatile Organic Compounds (VOCs) and is readily used in Europe and Canada for testing water samples. In order to detect low level contamination of water, it is essential for the static headspace sampling and GCMS analysis parameters to be enhanced. The linearity, detection limits and precision and accuracy of static headspace sampling will be compared with USEPA Method 8260 requirements.References: 1. Volatile Organic Compounds by Gas Chromatography/Mass Spectrometry (GC/MS); United States Environmental Protection Agency Method 8260B, Revision 2, December 1996.
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Multiplex miRNA Profiling for Biomarker Discovery and Verification Studies Using the FirePlex® Platform
M. Tackett, B. Heinrich, I. Diwan, G. Tejada, C. Rafferty, E. Atabakhsh, and D. Pregibon
PEAKS™ Software for the processing of timsTOF Pro PASEF data: identification and label-free quantitation
Markus Lubeck(1), Heiner Koch(1), Scarlet Beck(1), Paul Savage(2), Oliver Raether(1), Pierre-Olivier Schmit(2) Paul Shan (3) and Gary Kruppa (4)
PERFIL DE COMPONENTES VOLATILES DE MIELES FLORALES Y MONOFLORALES COLOMBIANAS
Salamanca,G. G. , Osorio, T. M.; Scriche, R. I.
MALDI Imaging Mass Spectrometry for the study of cardiovascular pathology
Takashi Nirasawa1, Megumi Terada2,3, Hiroko Namba2, Nobuto Kakuda2, Patrick Bruneval3, Hatsue Ishibashi-Ueda4 and Masaya Ikegawa1
Distinct deposition of amyloid-bspecies in brains with Alzheimer’s disease pathology visualized with MALDI imaging mass spectrometry
Nobuto Kakuda1, Tomohiro Miyasaka1, Takashi Nirasawa2, Shigeo Murayama3, Yasuo Ihara1 and Masaya Ikegawa1